{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T14:29:39Z","timestamp":1774621779224,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270197"],"award-info":[{"award-number":["82270197"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270211"],"award-info":[{"award-number":["82270211"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogenesis"],"DOI":"10.1038\/s41389-025-00544-7","type":"journal-article","created":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T17:38:43Z","timestamp":1738172323000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Targeting fucosyltransferase FUT8 as a prospective therapeutic approach for DLBCL"],"prefix":"10.1038","volume":"14","author":[{"given":"Hao","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuchen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuan","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meifang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yali","family":"Chai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8552-991X","authenticated-orcid":false,"given":"Wenzhuo","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2732-9354","authenticated-orcid":false,"given":"Bingzong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,29]]},"reference":[{"key":"544_CR1","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/35000501","volume":"403","author":"AA Alizadeh","year":"2000","unstructured":"Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000;403:503\u201311.","journal-title":"Nature"},{"key":"544_CR2","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","volume":"24","author":"B Chapuy","year":"2018","unstructured":"Chapuy B, Stewart C, Dunford AJ, Kim J, Kamburov A, Redd RA, et al. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. Nat Med. 2018;24:679\u201390.","journal-title":"Nat Med"},{"key":"544_CR3","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.ccell.2020.03.015","volume":"37","author":"GW Wright","year":"2020","unstructured":"Wright GW, Huang DW, Phelan JD, Coulibaly ZA, Roulland S, Young RM, et al. A probabilistic classification tool for genetic subtypes of diffuse large B cell lymphoma with therapeutic implications. Cancer Cell. 2020;37:551\u201368.e14.","journal-title":"Cancer Cell"},{"key":"544_CR4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/nrclinonc.2013.197","volume":"11","author":"M Roschewski","year":"2014","unstructured":"Roschewski M, Staudt LM, Wilson WH. Diffuse large B-cell lymphoma-treatment approaches in the molecular era. Nat Rev Clin Oncol. 2014;11:12\u201323.","journal-title":"Nat Rev Clin Oncol"},{"key":"544_CR5","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1182\/asheducation-2011.1.498","volume":"2011","author":"JW Friedberg","year":"2011","unstructured":"Friedberg JW. Relapsed\/refractory diffuse large B-cell lymphoma. Hematol Am Soc Hematol Educ Program. 2011;2011:498\u2013505.","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"544_CR6","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127:2375\u201390.","journal-title":"Blood"},{"key":"544_CR7","doi-asserted-by":"publisher","first-page":"8367","DOI":"10.3390\/molecules27238367","volume":"27","author":"A Naeem","year":"2022","unstructured":"Naeem A, Hu P, Yang M, Zhang J, Liu Y, Zhu W. et al. Natural products as anticancer agents: current status and future perspectives. Molecules. 2022;27:8367.","journal-title":"Molecules"},{"key":"544_CR8","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1752-4571.2008.00063.x","volume":"2","author":"JW Pepper","year":"2009","unstructured":"Pepper JW, Findlay CS, Kassen R, Spencer SL, Maley CC. Cancer research meets evolutionary biology. Evol Appl. 2009;2:62\u201370.","journal-title":"Evol Appl"},{"key":"544_CR9","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1111\/bph.14816","volume":"177","author":"SR Lin","year":"2020","unstructured":"Lin SR, Chang CH, Hsu CF, Tsai MJ, Cheng H, Leong MK, et al. Natural compounds as potential adjuvants to cancer therapy: preclinical evidence. Br J Pharmacol. 2020;177:1409\u201323.","journal-title":"Br J Pharmacol"},{"key":"544_CR10","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.2174\/0929867013372094","volume":"8","author":"AK Mukherjee","year":"2001","unstructured":"Mukherjee AK, Basu S, Sarkar N, Ghosh AC. Advances in cancer therapy with plant based natural products. Curr Med Chem. 2001;8:1467\u201386.","journal-title":"Curr Med Chem"},{"key":"544_CR11","doi-asserted-by":"crossref","unstructured":"Priya S, Satheeshkumar PK. Natural products from plants: recent developments in phytochemicals, phytopharmaceuticals, and plant-based neutraceuticals as anticancer agents. Funct Preserv Prop Phytochem. 2020:145\u201363.","DOI":"10.1016\/B978-0-12-818593-3.00005-1"},{"key":"544_CR12","doi-asserted-by":"publisher","first-page":"728","DOI":"10.2174\/1871520615666150304120643","volume":"15","author":"SM Nabavi","year":"2015","unstructured":"Nabavi SM, Habtemariam S, Daglia M, Nabavi SF. Apigenin and breast cancers: from chemistry to medicine. Anticancer Agents Med Chem. 2015;15:728\u201335.","journal-title":"Anticancer Agents Med Chem"},{"key":"544_CR13","first-page":"289","volume":"5","author":"SL Lim","year":"2015","unstructured":"Lim SL, Park SY, Kang S, Park D, Kim SH, Um JY, et al. Morusin induces cell death through inactivating STAT3 signaling in prostate cancer cells. Am J Cancer Res. 2015;5:289\u201399.","journal-title":"Am J Cancer Res"},{"key":"544_CR14","doi-asserted-by":"publisher","first-page":"3377","DOI":"10.1021\/jf703709r","volume":"56","author":"AM Pawlowska","year":"2008","unstructured":"Pawlowska AM, Oleszek W, Braca A. Quali-quantitative analyses of Flavonoids of Morus nigra L. and Morus alba L. (Moraceae) fruits. J Agric Food Chem. 2008;56:3377\u201380.","journal-title":"J Agric Food Chem"},{"key":"544_CR15","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3390\/ijms20020365","volume":"20","author":"W Zhu","year":"2019","unstructured":"Zhu W, Zhong Z, Liu S, Yang B, Komatsu S, Ge Z. et al. Organ-specific analysis of morus alba using a gel-free\/label-free proteomic technique. Int J Mol Sci. 2019;20:365.","journal-title":"Int J Mol Sci"},{"key":"544_CR16","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.3390\/ijms20092244","volume":"20","author":"TR Min","year":"2019","unstructured":"Min TR, Park HJ, Park MN, Kim B, Park SH. The root bark of Morus alba L. suppressed the migration of human non-small-cell lung cancer cells through inhibition of epithelial-mesenchymal transition mediated by STAT3 and Src. Int J Mol Sci. 2019;20:2244.","journal-title":"Int J Mol Sci"},{"key":"544_CR17","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.1002\/ptr.6783","volume":"34","author":"HJ Park","year":"2020","unstructured":"Park HJ, Chi GY, Choi YH, Park SH. The root bark of Morus alba L. regulates tumor-associated macrophages by blocking recruitment and M2 polarization of macrophages. Phytother Res. 2020;34:3333\u201344.","journal-title":"Phytother Res"},{"key":"544_CR18","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1080\/01635581.2021.1968444","volume":"74","author":"HJ Park","year":"2022","unstructured":"Park HJ, Park SH. Root bark of Morus Alba L. induced p53-independent apoptosis in human colorectal cancer cells by suppression of STAT3 activity. Nutr Cancer. 2022;74:1837\u201348.","journal-title":"Nutr Cancer"},{"key":"544_CR19","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.4014\/jmb.2109.09002","volume":"31","author":"GR Song","year":"2021","unstructured":"Song GR, Choi YJ, Park SJ, Shin S, Lee G, Choi HJ, et al. Root bark of Morus alba L. and its bioactive ingredient, ursolic acid, suppress the proliferation of multiple myeloma cells by inhibiting Wnt\/\u03b2-Catenin pathway. J Microbiol Biotechnol. 2021;31:1559\u201367.","journal-title":"J Microbiol Biotechnol"},{"key":"544_CR20","doi-asserted-by":"publisher","first-page":"516","DOI":"10.5551\/jat.10058","volume":"19","author":"JJ Lee","year":"2012","unstructured":"Lee JJ, Yang H, Yoo YM, Hong SS, Lee D, Lee HJ, et al. Morusinol extracted from Morus alba inhibits arterial thrombosis and modulates platelet activation for the treatment of cardiovascular disease. J Atheroscler Thromb. 2012;19:516\u201322.","journal-title":"J Atheroscler Thromb"},{"key":"544_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154765","volume":"114","author":"L Guo","year":"2023","unstructured":"Guo L, Dong Z, Zhang X, Yang Y, Hu X, Ji Y, et al. Morusinol extracted from Morus alba induces cell cycle arrest and apoptosis via inhibition of DNA damage response in melanoma by CHK1 degradation through the ubiquitin-proteasome pathway. Phytomedicine. 2023;114:154765.","journal-title":"Phytomedicine"},{"key":"544_CR22","doi-asserted-by":"publisher","first-page":"16016","DOI":"10.1021\/acs.jafc.3c01244","volume":"71","author":"X Zhang","year":"2023","unstructured":"Zhang X, Dong Z, Yang Y, Liu C, Li J, Sun W, et al. Morusinol extracted from morus alba inhibits cell proliferation and induces autophagy via FOXO3a nuclear accumulation-mediated cholesterol biosynthesis obstruction in colorectal cancer. J Agric Food Chem. 2023;71:16016\u201331.","journal-title":"J Agric Food Chem"},{"key":"544_CR23","doi-asserted-by":"publisher","first-page":"114798","DOI":"10.1016\/j.bcp.2021.114798","volume":"194","author":"YS Ren","year":"2021","unstructured":"Ren YS, Li HL, Piao XH, Yang ZY, Wang SM, Ge YW. Drug affinity responsive target stability (DARTS) accelerated small molecules target discovery: principles and application. Biochem Pharmacol. 2021;194:114798.","journal-title":"Biochem Pharmacol"},{"key":"544_CR24","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3390\/ijms22010455","volume":"22","author":"K Bastian","year":"2021","unstructured":"Bastian K, Scott E, Elliott DJ, Munkley J. FUT8 Alpha-(1,6)-fucosyltransferase in cancer. Int J Mol Sci.2021;22:455.","journal-title":"Int J Mol Sci."},{"key":"544_CR25","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1158\/0008-5472.CAN-16-3338","volume":"77","author":"LM Colli","year":"2017","unstructured":"Colli LM, Machiela MJ, Zhang H, Myers TA, Jessop L, Delattre O, et al. Landscape of combination immunotherapy and targeted therapy to improve cancer management. Cancer Res. 2017;77:3666\u201371.","journal-title":"Cancer Res"},{"key":"544_CR26","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.3109\/10428194.2013.879713","volume":"55","author":"SJ Nam","year":"2014","unstructured":"Nam SJ, Go H, Paik JH, Kim TM, Heo DS, Kim CW, et al. An increase of M2 macrophages predicts poor prognosis in patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone. Leuk Lymphoma. 2014;55:2466\u201376.","journal-title":"Leuk Lymphoma"},{"key":"544_CR27","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/hon.2142","volume":"33","author":"F Marchesi","year":"2015","unstructured":"Marchesi F, Cirillo M, Bianchi A, Gately M, Olimpieri OM, Cerchiara E, et al. High density of CD68+\/CD163+ tumour-associated macrophages (M2-TAM) at diagnosis is significantly correlated to unfavorable prognostic factors and to poor clinical outcomes in patients with diffuse large B-cell lymphoma. Hematol Oncol. 2015;33:110\u20132.","journal-title":"Hematol Oncol"},{"key":"544_CR28","doi-asserted-by":"publisher","first-page":"e0199398","DOI":"10.1371\/journal.pone.0199398","volume":"13","author":"X Gao","year":"2018","unstructured":"Gao X, Li J, Wang Y, Liu S, Yue B. Clinical characteristics and prognostic significance of EBER positivity in diffuse large B-cell lymphoma: a meta-analysis. PLoS ONE. 2018;13:e0199398.","journal-title":"PLoS ONE"},{"key":"544_CR29","doi-asserted-by":"publisher","first-page":"4011","DOI":"10.1016\/j.apsb.2022.08.022","volume":"12","author":"Y Zhu","year":"2022","unstructured":"Zhu Y, Ouyang Z, Du H, Wang M, Wang J, Sun H, et al. New opportunities and challenges of natural products research: When target identification meets single-cell multiomics. Acta Pharm Sin B. 2022;12:4011\u201339.","journal-title":"Acta Pharm Sin B"},{"key":"544_CR30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0304-4165(99)00166-X","volume":"1473","author":"E Miyoshi","year":"1999","unstructured":"Miyoshi E, Noda K, Yamaguchi Y, Inoue S, Ikeda Y, Wang W, et al. The alpha1-6-fucosyltransferase gene and its biological significance. Biochim Biophys Acta. 1999;1473:9\u201320.","journal-title":"Biochim Biophys Acta"},{"key":"544_CR31","doi-asserted-by":"publisher","first-page":"41r","DOI":"10.1093\/glycob\/cwg054","volume":"13","author":"DJ Becker","year":"2003","unstructured":"Becker DJ, Lowe JB. Fucose: biosynthesis and biological function in mammals. Glycobiology. 2003;13:41r\u201353r.","journal-title":"Glycobiology"},{"key":"544_CR32","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1093\/glycob\/cwx034","volume":"27","author":"M Schneider","year":"2017","unstructured":"Schneider M, Al-Shareffi E, Haltiwanger RS. Biological functions of fucose in mammals. Glycobiology. 2017;27:601\u201318.","journal-title":"Glycobiology"},{"key":"544_CR33","doi-asserted-by":"publisher","first-page":"11064","DOI":"10.1074\/jbc.M116.720789","volume":"291","author":"Q Yang","year":"2016","unstructured":"Yang Q, Wang LX. Mammalian \u03b1-1,6-fucosyltransferase (FUT8) is the sole enzyme responsible for the N-acetylglucosaminyltransferase I-independent core fucosylation of high-mannose N-glycans. J Biol Chem. 2016;291:11064\u201371.","journal-title":"J Biol Chem"},{"key":"544_CR34","doi-asserted-by":"publisher","first-page":"15791","DOI":"10.1073\/pnas.0507375102","volume":"102","author":"X Wang","year":"2005","unstructured":"Wang X, Inoue S, Gu J, Miyoshi E, Noda K, Li W, et al. Dysregulation of TGF-beta1 receptor activation leads to abnormal lung development and emphysema-like phenotype in core fucose-deficient mice. Proc Natl Acad Sci USA. 2005;102:15791\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"544_CR35","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/bs.acr.2014.11.005","volume":"126","author":"A Mehta","year":"2015","unstructured":"Mehta A, Herrera H, Block T. Glycosylation and liver cancer. Adv Cancer Res. 2015;126:257\u201379.","journal-title":"Adv Cancer Res"},{"key":"544_CR36","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1093\/jb\/mvn011","volume":"143","author":"E Miyoshi","year":"2008","unstructured":"Miyoshi E, Moriwaki K, Nakagawa T. Biological function of fucosylation in cancer biology. J Biochem. 2008;143:725\u20139.","journal-title":"J Biochem"},{"key":"544_CR37","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/bs.acr.2014.11.004","volume":"126","author":"S Holst","year":"2015","unstructured":"Holst S, Wuhrer M, Rombouts Y. Glycosylation characteristics of colorectal cancer. Adv Cancer Res. 2015;126:203\u201356.","journal-title":"Adv Cancer Res"},{"key":"544_CR38","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s10719-016-9653-7","volume":"33","author":"S Takahashi","year":"2016","unstructured":"Takahashi S, Sugiyama T, Shimomura M, Kamada Y, Fujita K, Nonomura N, et al. Site-specific and linkage analyses of fucosylated N-glycans on haptoglobin in sera of patients with various types of cancer: possible implication for the differential diagnosis of cancer. Glycoconj J. 2016;33:471\u201382.","journal-title":"Glycoconj J"},{"key":"544_CR39","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/biom6020025","volume":"6","author":"Y Kizuka","year":"2016","unstructured":"Kizuka Y, Taniguchi N. Enzymes for N-glycan branching and their genetic and nongenetic regulation in cancer. Biomolecules. 2016;6:25.","journal-title":"Biomolecules"},{"key":"544_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2024.107492","volume":"149","author":"Y Lv","year":"2024","unstructured":"Lv Y, Zhang Z, Wang M, Wang Y, Chen M, Jia J, et al. Discovery of novel FUT8 inhibitors with promising affinity and in vivo efficacy for colorectal cancer therapy. Bioorg Chem. 2024;149:107492.","journal-title":"Bioorg Chem"},{"key":"544_CR41","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1021\/acs.jproteome.3c00833","volume":"23","author":"R L\u00f3pez-Cort\u00e9s","year":"2024","unstructured":"L\u00f3pez-Cort\u00e9s R, Muinelo-Romay L, Fern\u00e1ndez-Briera A, Gil Mart\u00edn E. High-throughput mass spectrometry analysis of N-glycans and protein markers after FUT8 knockdown in the syngeneic SW480\/SW620 colorectal cancer cell model. J Proteome Res. 2024;23:1379\u201398.","journal-title":"J Proteome Res"},{"key":"544_CR42","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41568-019-0109-9","volume":"19","author":"PA Jones","year":"2019","unstructured":"Jones PA, Ohtani H, Chakravarthy A, De Carvalho DD. Epigenetic therapy in immune-oncology. Nat Rev Cancer. 2019;19:151\u201361.","journal-title":"Nat Rev Cancer"},{"key":"544_CR43","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.bbrc.2010.01.011","volume":"392","author":"L Liu","year":"2010","unstructured":"Liu L, Chen B, Qin S, Li S, He X, Qiu S, et al. A novel histone deacetylase inhibitor Chidamide induces apoptosis of human colon cancer cells. Biochem Biophys Res Commun. 2010;392:190\u20135.","journal-title":"Biochem Biophys Res Commun"},{"key":"544_CR44","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00280-011-1766-x","volume":"69","author":"ZQ Ning","year":"2012","unstructured":"Ning ZQ, Li ZB, Newman MJ, Shan S, Wang XH, Pan DS, et al. Chidamide (CS055\/HBI-8000): a new histone deacetylase inhibitor of the benzamide class with antitumor activity and the ability to enhance immune cell-mediated tumor cell cytotoxicity. Cancer Chemother Pharmacol. 2012;69:901\u20139.","journal-title":"Cancer Chemother Pharmacol"},{"key":"544_CR45","doi-asserted-by":"publisher","first-page":"13","DOI":"10.12703\/P6-13","volume":"6","author":"FO Martinez","year":"2014","unstructured":"Martinez FO, Gordon S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep. 2014;6:13.","journal-title":"F1000Prime Rep"},{"key":"544_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173090","volume":"877","author":"C Yunna","year":"2020","unstructured":"Yunna C, Mengru H, Lei W, Weidong C. Macrophage M1\/M2 polarization. Eur J Pharmacol. 2020;877:173090.","journal-title":"Eur J Pharmacol"}],"container-title":["Oncogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41389-025-00544-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41389-025-00544-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41389-025-00544-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T17:38:46Z","timestamp":1738172326000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41389-025-00544-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,29]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["544"],"URL":"https:\/\/doi.org\/10.1038\/s41389-025-00544-7","relation":{},"ISSN":["2157-9024"],"issn-type":[{"value":"2157-9024","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,29]]},"assertion":[{"value":"5 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations. The Soochow University Animal Ethics approved the animal experiment (Approval No.: 202207A0710). All of the ethics guidelines pertaining to animal research were followed in terms of both animal care and experimentation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"1"}}